Lilly, J&J Fall After Schizophrenia Drug Trial Published: Nov 26, 2003 Shares of Eli Lilly and Co. and Johnson & Johnson fell on Wednesday following a study in which a cheap older generic schizophrenia drug was about as effective as Lilly's costly Zyprexa treatment. Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news